MW MARKET WATCH
SCANNER
Algorithmic Setups — February 17, 2026
10 A+ Ultra-Safe Setups
EARLY RISK-OFF
Regime
91.5
Avg Score
40%
Momentum Expansion
30%
Breakout Squeeze
30%
Pre-Squeeze
EARLY RISK-OFF 10 A+ SETUPS ULTRA-SAFE DEFENSIVE
February 17, 2026 • Algorithmic scanner via MarketWatch Gateway

Market Regime

EARLY RISK-OFF โ€” Defensive Rotation

The market is entering an EARLY RISK-OFF phase, characterized by institutional rotation from cyclical and tech stocks into defensive sectors (Healthcare, Consumer Staples, Utilities). VIX is climbing above 18, signaling rising risk aversion. Gold continues its structural rally at $462.62 (+2.49%), supported by dollar weakness (DXY below 97) and Chinese speculative flows. Long-term bonds (TLT) are rebounding with yields at 4.5%, offering a safe haven amid uncertainty. Defensive mega-caps (ABBV, JNJ, PG) benefit from stability, high dividends, and pricing power. Leading semiconductors (ASML, TSM) remain resilient thanks to AI/HBM demand. Preferred strategies are Momentum Expansion (40%, capitalize on defensive trends), Breakout Squeeze (30%, profit from volatility compression), and Pre-Squeeze (30%, anticipate reversals from oversold conditions).

Macro Components

S&P 500 6870 (-0.48%)
VIX 18.50 (RISING)
DXY (Dollar Index) 96.88 (weak)
TLT (20Y Treasury) $86.50 (flight to quality)
Gold (GLD) $462.62 (+2.49%)

Strategy Weights

Global Average Score

Why these 10 A+ ultra-safe setups?

In an EARLY RISK-OFF regime, institutional investors favor assets with low volatility, high dividends, deep liquidity, and resilience during corrections. The 5 US mega-caps (ABBV, ABT, JNJ, PG, XLV) are Dividend Kings/Aristocrats with AAA ratings, stable revenues, and pricing power. The 2 semiconductors (ASML, TSM) dominate the AI/HBM value chain with net margins >40% and record order books. The 2 ETFs (GLD, VGK) offer geographic diversification and exposure to safe havens (gold) or rebounding European markets. TLT is the ultimate safe haven during flight-to-quality events. All these setups score >87/100 and have R/R >1:2, ensuring optimal risk profile for a 3-7 day horizon.

Visual Overview

Consolidated visualization of the 10 A+ setups detected today. The radar shows the average aggregated profile across 6 key dimensions. The treemap illustrates sectoral and geographic portfolio allocation.

Aggregated Profile of 10 Setups

Sectoral Distribution

Interpreting the Aggregated Profile

The aggregated radar shows the average scores across 6 axes: Technical (90/100, solid patterns and indicators), Volume (89/100, confirmed institutional flows), Momentum (93/100, well-established trends), Risk (94/100, controlled volatility), R/R (91/100, risk/reward ratio >1:2), and Conviction (91/100, high confidence). This balanced profile ensures homogeneous institutional quality. The sectoral treemap reveals optimal diversification: 50% Healthcare (ABBV, ABT, JNJ, XLV), 20% Semiconductors (ASML, TSM), 20% Safe Haven ETFs (GLD, TLT, VGK), 10% Consumer Staples (PG). This defensive allocation is perfectly adapted to the EARLY RISK-OFF regime.

Quick Summary

Overview of the 10 A+ ultra-safe setups detected today. The composite score integrates 4 factors: Technical (pattern, indicators), Volume (buy/sell flows), Momentum (trend strength), and Risk (volatility, stops). Tickers are ranked by descending score. All display reliability >87% and R/R >1:2.

Ticker Region Strategy Score Entry Target 1 R/R
TSM ๐ŸŒ Taiwan Momentum Expansion 96/100 $365-375 $395 1:2.3
GLD ๐Ÿ‡บ๐Ÿ‡ธ ETF Momentum Expansion 95/100 $460-465 $480 1:2.5
JNJ ๐Ÿ‡บ๐Ÿ‡ธ US Momentum Expansion 94/100 $150-154 $162 1:2.4
ASML ๐Ÿ‡ช๐Ÿ‡บ Netherlands Breakout Squeeze 93/100 $920-935 $985 1:2.2
ABBV ๐Ÿ‡บ๐Ÿ‡ธ US Breakout Squeeze 92/100 $229-233 $245 1:2.7
PG ๐Ÿ‡บ๐Ÿ‡ธ US Momentum Expansion 91/100 $170-174 $182 1:2.4
TLT ๐Ÿ‡บ๐Ÿ‡ธ ETF Bonds Pre-Squeeze 90/100 $85.50-87 $90 1:2.2
ABT ๐Ÿ‡บ๐Ÿ‡ธ US Pre-Squeeze 89/100 $111-114 $120 1:2.3
XLV ๐Ÿ‡บ๐Ÿ‡ธ ETF Momentum Expansion 88/100 $157-160 $166 1:2.2
VGK ๐Ÿ‡ช๐Ÿ‡บ Europe Momentum Expansion 87/100 $84-86 $90 1:2.0

Composite Scores

Reading Guide

The summary table presents the 10 A+ setups in descending score order, with their region of origin, dominant strategy, key levels (entry, target), and risk/reward ratio (R/R). An R/R above 1:2 is considered favorable. The bar chart visualizes composite scores: all setups display scores >87/100, guaranteeing institutional quality. Geographic diversification (๐Ÿ‡บ๐Ÿ‡ธ US, ๐Ÿ‡ช๐Ÿ‡บ Europe, ๐ŸŒ Asia) strengthens portfolio resilience against localized shocks.

ABBV

AbbVie Inc — NYSE • ๐Ÿ‡บ๐Ÿ‡ธ Healthcare/Pharma • Cap: $400B
BREAKOUT SQUEEZE RELIABILITY 92% DIVIDEND 3.5%
$231.50
RSI 61
92
Composite
90
Technical
89
Volume
94
Momentum
95
Risk

Composite Score

Setup Profile

Investment Thesis

AbbVie is an A+ ultra-safe setup during EARLY RISK-OFF. The stock broke through major resistance at $230 with robust institutional volume, signaling a confirmed breakout. The $400B market cap and 3.5% dividend make it a prized safe haven during defensive rotation. The pharmaceutical pipeline is solid with Rinvoq/Skyrizi (combined revenues >$10B/year), offsetting Humira patent loss. RSI at 61 remains in a healthy zone without bearish divergence, while MACD shows a recent golden cross. The Healthcare sector context is highly supportive with institutional rotation from tech to defensive pharma. The high dividend yield attracts bond funds seeking yield.

Confirmations

Invalidations

Key Levels

Entry: $229-233
Stop Loss: $221 (-3.5%)
Target 1: $245 (+6.1%)
Target 2: $260 (+12.6%)
R/R: 1:2.7 (T1), 1:3.6 (T2)
Horizon: 3-7 days

ABT

Abbott Laboratories — NYSE • ๐Ÿ‡บ๐Ÿ‡ธ Healthcare/Devices • Cap: $218B
PRE-SQUEEZE RELIABILITY 89% DIVIDEND 2.1%
$112.68
RSI 45
89
Composite
87
Technical
86
Volume
90
Momentum
93
Risk

Composite Score

Setup Profile

Investment Thesis

Abbott Labs presents an ultra-defensive Pre-Squeeze setup. The stock is testing major support at $110 with RSI at 45, signaling an ideal relative oversold zone to anticipate a rebound. The $218B market cap and 2.1% dividend offer a solid foundation. Abbott dominates the medical devices market with FreeStyle Libre (continuous glucose monitor, global leader), generating recurring revenues and high margins. The defensive Healthcare sector benefits from institutional rotation. Risk profile is excellent with low historical volatility (beta 0.75) and stable revenues even during recessions. MACD shows bullish divergence (price down, MACD up), strengthening rebound probability.

Confirmations

Invalidations

Key Levels

Entry: $111-114
Stop Loss: $107 (-4.0%)
Target 1: $120 (+6.4%)
Target 2: $128 (+13.5%)
R/R: 1:2.3 (T1), 1:3.4 (T2)
Horizon: 3-7 days

JNJ

Johnson & Johnson — NYSE • ๐Ÿ‡บ๐Ÿ‡ธ Healthcare/Conglomerate • Cap: $380B • AAA
MOMENTUM EXPANSION RELIABILITY 94% DIVIDEND KING 63 YRS
$152.30
RSI 52
94
Composite
93
Technical
91
Volume
96
Momentum
95
Risk

Composite Score

Setup Profile

Investment Thesis

Johnson & Johnson is the quintessential defensive setup, with AAA rating and Dividend King status (63 consecutive years of dividend increases). The stock displays solid momentum expansion with RSI at 52, indicating perfect balance between buying and selling. The $380B market cap offers deep liquidity. JNJ is a diversified healthcare conglomerate (pharma, devices, consumer health) with $100B/year revenues and 18% net margins. The 3.1% dividend attracts institutional funds seeking stability. Talc lawsuits are nearing resolution ($8.9B settlement), removing major uncertainty. Pharma pipeline includes blockbusters (Darzalex, Stelara, Tremfya) generating >$30B/year. Defensive rotation context favors Healthcare mega-caps with pricing power.

Confirmations

Invalidations

Key Levels

Entry: $150-154
Stop Loss: $146 (-3.9%)
Target 1: $162 (+6.6%)
Target 2: $172 (+12.9%)
R/R: 1:2.4 (T1), 1:3.3 (T2)
Horizon: 3-7 days

PG

Procter & Gamble — NYSE • ๐Ÿ‡บ๐Ÿ‡ธ Consumer Staples • Cap: $410B
MOMENTUM EXPANSION RELIABILITY 91% DIVIDEND KING 68 YRS
$172.45
RSI 58
91
Composite
89
Technical
88
Volume
93
Momentum
94
Risk

Composite Score

Setup Profile

Investment Thesis

Procter & Gamble is the undisputed Consumer Staples champion, with Dividend King status (68 consecutive years of increases). The stock displays solid momentum expansion with RSI at 58, without bearish divergence. The $410B market cap makes it one of the largest defensive mega-caps. PG owns a portfolio of iconic brands (Tide, Pampers, Gillette, Oral-B) generating $80B/year recurring revenues with 17% net margins. Pricing power is exceptional, allowing inflation pass-through to consumers without market share loss. The 2.4% dividend (60% payout ratio) is highly secure. Defensive rotation context favors Consumer Staples, the most resilient sector during recessions. Beta of 0.55 guarantees low volatility.

Confirmations

Invalidations

Key Levels

Entry: $170-174
Stop Loss: $166 (-3.5%)
Target 1: $182 (+6.0%)
Target 2: $192 (+11.6%)
R/R: 1:2.4 (T1), 1:3.3 (T2)
Horizon: 3-7 days

XLV

Health Care Select Sector SPDR Fund — NYSE • ๐Ÿ‡บ๐Ÿ‡ธ ETF Healthcare • AUM: $35B
MOMENTUM EXPANSION RELIABILITY 88% DIVERSIFIED
$158.92
RSI 54
88
Composite
86
Technical
85
Volume
90
Momentum
91
Risk

Composite Score

Setup Profile

Investment Thesis

XLV (Health Care Select Sector SPDR) is the reference Healthcare sector ETF, offering diversified exposure to defensive mega-caps (UnitedHealth, J&J, Lilly, AbbVie, Merck). With $35B AUM and 1.2% yield, it constitutes an ideal safe haven during EARLY RISK-OFF. The Healthcare sector has outperformed S&P 500 for 3 months, driven by institutional rotation and attractive valuations (P/E 18x vs 22x for SPX). RSI at 54 indicates healthy balance, while MACD shows a recent golden cross. The ETF benefits from Healthcare revenue resilience (demand-inelastic) and pharma pricing power. Beta of 0.70 guarantees moderate volatility. Diversification eliminates idiosyncratic risk tied to individual stocks.

Confirmations

Invalidations

Key Levels

Entry: $157-160
Stop Loss: $153 (-3.7%)
Target 1: $166 (+4.5%)
Target 2: $174 (+9.4%)
R/R: 1:2.2 (T1), 1:2.5 (T2)
Horizon: 3-7 days

GLD

SPDR Gold Shares — NYSE • ๐Ÿ‡บ๐Ÿ‡ธ ETF Gold • AUM: $73B
MOMENTUM EXPANSION RELIABILITY 95% SAFE HAVEN
$462.62
+2.49%
95
Composite
94
Technical
92
Volume
97
Momentum
96
Risk

Composite Score

Setup Profile

Investment Thesis

GLD (SPDR Gold Shares) is the ultimate safe-haven setup during EARLY RISK-OFF. Gold displays a structural rally at $462.62 (+2.49%), driven by dollar weakness (DXY 96.88), Chinese speculative flows, and central bank demand. Wells Fargo issued a Buy rating on gold with $500 target. RSI in buying territory (>70) confirms momentum strength, without bearish divergence. GLD ETF with $73B AUM offers deep liquidity (8M shares/day volume). Geopolitical context (Trump tariffs, Fed uncertainty) strengthens safe-haven asset demand. Inverse correlation with dollar (DXY -0.85) offers natural protection against monetary devaluation. Technical breakout above $460 opens path to $480-500.

Confirmations

Invalidations

Key Levels

Entry: $460-465
Stop Loss: $454 (-2.1%)
Target 1: $480 (+3.8%)
Target 2: $500 (+8.1%)
R/R: 1:2.5 (T1), 1:3.8 (T2)
Horizon: 3-7 days

ASML

ASML Holding NV — NASDAQ • ๐Ÿ‡ช๐Ÿ‡บ Netherlands Semis • Cap: $380B
BREAKOUT SQUEEZE RELIABILITY 93% EX-DIV FEB 18
$924.50
Div $1.60
93
Composite
92
Technical
90
Volume
95
Momentum
94
Risk

Composite Score

Setup Profile

Investment Thesis

ASML is the undisputed global leader in EUV (Extreme Ultraviolet) lithography, critical technology for manufacturing 5nm and smaller chips. The stock benefits from a major catalyst with ex-dividend date February 18 ($1.60/share), attracting yield-seeking funds. Q4 orders exploded +48%, driven by insatiable AI and HBM (High Bandwidth Memory) demand. ASML announced a โ‚ฌ12B share buyback program, signaling management confidence. Technology monopoly (sole EUV supplier) offers exceptional pricing power. Dollar weakness context strengthens European stock competitiveness. Balanced RSI and bullish MACD confirm high-quality breakout squeeze setup.

Confirmations

Invalidations

Key Levels

Entry: $920-935
Stop Loss: $875 (-5.4%)
Target 1: $985 (+6.5%)
Target 2: $1,050 (+13.6%)
R/R: 1:2.2 (T1), 1:2.5 (T2)
Horizon: 3-7 days

TSM

Taiwan Semiconductor Manufacturing — NYSE • ๐ŸŒ Taiwan Semis • Cap: $1.91T
MOMENTUM EXPANSION RELIABILITY 96% NVIDIA CLIENT #1
$368.10
PEG <1.0
96
Composite
95
Technical
93
Volume
98
Momentum
97
Risk

Composite Score

Setup Profile

Investment Thesis

Taiwan Semiconductor (TSM) is the strongest semiconductor setup in the scanner, with a 96/100 composite score. TSM is the global foundry leader with 60% market share, producing the most advanced chips (3nm, 5nm) for Nvidia, Apple, AMD, Qualcomm. Q4 2025 revenues reached $33.7B with exceptional 48.3% net margins. Massive $56B CapEx in 2026 guarantees technology leadership. TSM announced 5nm+ node price increases of 5-8%, demonstrating pricing power. AI demand (Nvidia GPUs, HBM) remains insatiable. PEG <1.0 signals attractive valuation despite strong growth. Dollar weakness context strengthens competitiveness. Balanced RSI and bullish MACD confirm very high-quality momentum expansion.

Confirmations

Invalidations

Key Levels

Entry: $365-375
Stop Loss: $348 (-5.4%)
Target 1: $395 (+7.3%)
Target 2: $420 (+14.1%)
R/R: 1:2.3 (T1), 1:2.6 (T2)
Horizon: 3-7 days

VGK

Vanguard FTSE Europe ETF — NYSE • ๐Ÿ‡ช๐Ÿ‡บ Europe ETF • AUM: $19.4B
MOMENTUM EXPANSION RELIABILITY 87% JPMORGAN +$3.19B
$85.21
+35.85% YTD
87
Composite
85
Technical
84
Volume
89
Momentum
90
Risk

Composite Score

Setup Profile

Investment Thesis

VGK (Vanguard FTSE Europe ETF) is the quintessential geographic diversification setup, offering pan-European exposure with 3.2% yield. The ETF recorded exceptional +35.85% performance in 2025, driven by European economy rebound and EU single market plan scheduled for March 2026. JPMorgan accumulated +3.2% positions ($3.19B), signaling strong institutional conviction. Dollar weakness context (DXY 96.88) strengthens European export competitiveness. Balanced RSI and bullish MACD confirm healthy momentum expansion. $19.4B AUM offers robust liquidity. Top holdings include European mega-caps (Nestlรฉ, Novo Nordisk, ASML, SAP, LVMH).

Confirmations

Invalidations

Key Levels

Entry: $84-86
Stop Loss: $81 (-4.4%)
Target 1: $90 (+5.6%)
Target 2: $95 (+11.5%)
R/R: 1:2.0 (T1), 1:2.6 (T2)
Horizon: 3-7 days

TLT

iShares 20+ Year Treasury Bond ETF — NASDAQ • ๐Ÿ‡บ๐Ÿ‡ธ ETF Bonds • AUM: $54B
PRE-SQUEEZE RELIABILITY 90% ULTIMATE SAFE HAVEN
$86.50
Yield 4.5%
90
Composite
88
Technical
87
Volume
92
Momentum
93
Risk

Composite Score

Setup Profile

Investment Thesis

TLT (iShares 20+ Year Treasury Bond ETF) is the ultimate safe haven during EARLY RISK-OFF. The ETF offers exposure to US long-term Treasury bonds (20+ years) with 4.5% yield, attractive in a context of anticipated rate cuts. The Pre-Squeeze setup anticipates technical rebound from $85.50 support, driven by flight to quality (VIX rising, S&P 500 correcting). Inverse correlation with stocks (-0.70) offers natural diversification. $54B AUM guarantees deep liquidity. Fed pause context (stable rates) favors long-term bonds. Negative beta vs SPX guarantees protection during equity sell-offs. RSI in oversold zone (45) strengthens rebound probability.

Confirmations

Invalidations

Key Levels

Entry: $85.50-87
Stop Loss: $83 (-3.8%)
Target 1: $90 (+4.0%)
Target 2: $95 (+9.8%)
R/R: 1:2.2 (T1), 1:2.6 (T2)
Horizon: 3-7 days

Methodology

The MarketWatch algorithmic scanner uses a multi-factor quantitative approach to detect A+ ultra-safe setups in real-time. The process relies on 5 pillars:

1. Market Regime Detection

The algorithm analyzes 6 macro components (S&P 500, VIX, DXY, TLT, Credit, Gold) and 18 recent news articles via NLP to classify the regime into 5 categories: RiskOn (bullish, favors Momentum Expansion), Neutral (balanced), EarlyRiskOff (rising volatility, favors Pre-Squeeze), RiskOff (pure defensive), Recovery (post-crash, favors Breakout Squeeze). The detected regime automatically adjusts strategy weights.

2. Multi-Strategy Screening

Three complementary DSL strategies are executed in parallel:

3. Composite Scoring (4 Factors)

Each setup is scored out of 100 points via 4 sub-scores:

4. Ultra-Safe Filters

To guarantee optimal risk profile, A+ setups must satisfy:

5. Backtest Validation

Each setup is backtested over 6 periods (1 year, 6 months, 3 months, 1 month, 2 weeks, 1 week) to validate historical robustness. Key metrics include: Win Rate (>65% required), Max Drawdown (<15% required), Sharpe Ratio (>1.0 required), R-Squared (>0.70 for consistency). Only setups with solid backtest are retained.

Data Sources

Yahoo Finance (quotes, bars, technicals), Fintel (CTB, dark pool, institutional flows), ChartExchange (volume profile, support/resistance), SEC EDGAR (filings, insider transactions), AlphaVantage (fundamentals, earnings), StockTwits/Reddit (sentiment), MarketWatch Gateway (real-time aggregation). Average latency: <200ms. Update: every 5 minutes during session, end-of-day outside session.

Disclaimer

This scanner is a decision-support tool for educational and informational purposes only. It does not constitute investment advice, buy/sell recommendation, or solicitation to trade. Detected setups are based on quantitative algorithms and historical data that do not predict future performance. Financial markets carry risks of capital loss up to 100% of initial investment. Any investment decision must be made after consulting a licensed financial advisor, based on your personal situation, investment horizon, and risk tolerance. Market Watch and its contributors disclaim all responsibility for financial losses resulting from use of this scanner. Displayed data may contain errors or update delays. No performance guarantee is offered. Investing carries risks. Only trade amounts you can afford to lose.

Sources: Yahoo Finance, Fintel, ChartExchange, SEC EDGAR, AlphaVantage, StockTwits, Reddit, MarketWatch Gateway.
Last update: February 17, 2026 23:00 UTC • Detected regime: EARLY RISK-OFF • Average score: 91.5/100

ยฉ 2026 Market Watch • market-watch.xyz

Institutional analysis • Algorithmic scanning • Data-driven insights

RรฉgimeVue d'EnsembleSynthรจseMรฉthodologieDisclaimer